gonads Flashcards

menopause: define menopause and climacteric, explain the clinical features, summarise treatment options including the advantages and disadvantages

1
Q

define menopause

A

permanent cessation of menstuation due to loss of ovarian follicular activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

average age of menopause

A

51 (range from 45-55)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define climacteric

A

transition period to menopause, where periods become irregular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2 major symptoms of menopause

A

hot flushes (head, neck, upper chest), urogenital atrophy and dyspareunia (difficult/painful sexual intercourse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

4 other symptoms of menopause

A

sleep disturbance (most common), depression, decreased libido, joint pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

normal hypothalamo-pituitary gonadal axis

A

hypothalamus -> GnRH -> anterior pituitary -> LH and FSH -> ovaries -> oestradiol and inhibin B -> negative feedback on hypothalamus and pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

hypothalamo-pituitary gonadal axis: hormonal changes during menopause

A

hypothalamus -> GnRH -> anterior pituitary -> increased LH and FSH -> ovaries -> reduced release of oestradiol and inhibin B -> reduced negative feedback on hypothalamus and pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 complications of menopause

A

osteoporosis, cardiovascular risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why does menopause cause osteoporosis, and effect on fracture risk

A

oestrogen deficiency causing loss of bone matrix; 10-fold increased fracture risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

menopause effect on cardiovascular disease risk

A

protected against CVD before menopause due to oestrogen, but have same risk as men by age of 70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how can vasomotor symptoms (hot flushes) be controlled in menopause

A

hormone replacement therapy (always weigh risk and benefits)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

hormonal replacement therapy: what does oestrogen promote

A

endometrial proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hormonal replacement therapy: risk of using oestrogen, and why use combined oestrogen and progesterone

A

endometrial carcinoma, so combined to prevent endometrial hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what hormone replacement therapy would be prescribed following a hysterectomy

A

oestogen only as no endometrium as no uterus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2 hormone replacement therapy formulations and when given

A

cyclical: oestrogen everyday and progestogens every 12-14 days; continuous combined

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hormone replacement therapy formulations: 4 oestrogen preparations (amount, administration and how often)

A

oral estradiol (1mg), oral conjugated equine oestrogen (0.625 mg), transdermal (patch) oestradiol (50 microgram/day), intravaginal

17
Q

2 pharmacokinetic features of oestradiol

A

well absorbed but low bioavailability (majority undergoes first pass metabolism) so much higher dose vs transdermal skin patch or ethinyl oestradiol

18
Q

what is estrone sulphate

A

“conjugated” oestrogen

19
Q

what is ethinyl oestradiol and what does the ethinyl group do

A

semi-synthetic oestrogen; ethinyl group protects molecule from first pass metabolism

20
Q

besides enteral, how else can more oestrogens be administered

A

via transdermal skin patches, so require lower dose

21
Q

5 side effects of hormone replacement therapy

A

breast cancer, coronary heart disease, deep vein thrombosis, stroke, gallstones

22
Q

absolute risk of complications for healthy symptomatic postmenopausal women in 50s taking hormone replacement therapy for 5 years

23
Q

hormone replacement therapy and coronary heart disease: what is important

A

timing of exposure (mean age in one study was 63 years, not a 50 year old)

24
Q

hormone replacement therapy and coronary heart disease: risk in younger menopausal women, or women < 10 years since menopause, or 50-59 years

A

no excess risk

25
effect of oestrogen and synthetic progestins on lipid profile and endothelial function
oestrogen has beneficial effects on lipid profile and endothelial function (females have fewer CVD than men), but synthetic progestins negate these effects
26
effects of oestrogen and synthetic progestins in older women (>60) with atherosclerosis, and effect on CVD risk
increased prothrombotic and proinflammatory effects, increasing CVD risk
27
what is tibolone and what actions does it have
synthetic prohormone with oestrogenic, progestogenic and weak androgenic actions
28
effect of tibolone on fracture risk
reduces fracture risk
29
2 risks of using tibolone
increases stroke risk, possibly increases breast cancer risk
30
what is raloxifene
selective oestrogen receptor modulator
31
raloxifene oestrogenic effects in bone
reduces risk of vertebral fractures
32
raloxifene anti-oestrogenic effects in breat and uterus
reduces breast cancer risk
33
2 drawbacks of raloxifene
doesn't reduce vasomotor symptoms of menopause (must treat with HRT), and increases risk of venous thromboembolism and fatal stroke
34
tamoxifen effect on breast tissue and subsequent use
anti-oestrogenic effect, so used to treat oestrogen-dependent breast tumours and metastatic breast cancers
35
define premature ovarian insufficiency, and % women affected
where menopause occurs before age of 40; occurs in 1% of women
36
4 causes of premature ovarian insufficiency
autoimmune, surgery, chemotherapy, radiation